Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
09/13/2005 | US6943195 Cycloalkenone derivative |
09/13/2005 | US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
09/13/2005 | US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
09/13/2005 | US6943174 6,5-Fused bicyclic heterocycles |
09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
09/13/2005 | US6943171 For therapy of urological, vascular or pulmonary disorders |
09/13/2005 | US6943158 for treating a fibroblast growth factor receptors (FGFR) kinase mediated disorder such as atherosclerosis |
09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
09/13/2005 | CA2371587C Piperidine derivatives useful as ccr5 antagonists |
09/13/2005 | CA2371583C Piperazine derivatives useful as ccr5 antagonists |
09/09/2005 | WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha |
09/09/2005 | WO2005082905A1 Bicyclic heterocyclic compound |
09/09/2005 | WO2005082887A1 Pyrimidine derivative |
09/09/2005 | WO2005082865A1 Fused bicyclic pyrimidine derivative |
09/09/2005 | WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2) |
09/09/2005 | WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1) |
09/09/2005 | WO2005082847A1 Bicyclo derivative |
09/09/2005 | WO2005082845A1 Novel therapies with somatostatin receptor agonists |
09/09/2005 | WO2005082844A1 Treatment of diseases by using a somatostatin receptor agonist |
09/09/2005 | WO2005082402A1 Preventive/therapeutic agent for organ fibrosis |
09/09/2005 | WO2005082388A1 Extracts of scutellaria for the treatment of sars |
09/09/2005 | WO2005082373A1 Medicinal eudistomin derivative composition |
09/09/2005 | WO2003057854A3 Novel proteins and nucleic acids encoding same |
09/09/2005 | CA2557541A1 Pyrimidine derivatives |
09/09/2005 | CA2557444A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation |
09/09/2005 | CA2557144A1 Non-peptidyl agents with phsp20-like activity, and uses thereof |
09/09/2005 | CA2556914A1 Amines and amides for the treatment of diseases |
09/09/2005 | CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2) |
09/09/2005 | CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1) |
09/08/2005 | US20050197383 Quaternary ammonium compounds and their use as anti-tussive agents |
09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
09/08/2005 | US20050197352 Imidazo-substituted compounds as p38 kinase inhibitors |
09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
09/08/2005 | US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
09/08/2005 | US20050197323 Full or partial glucocorticosteroid replacement therapy for obstructive pulmonary bronchial diseases |
09/08/2005 | US20050196428 Dilute aqueous solution containing epidermal growth factor in gel |
09/08/2005 | US20050196346 Micronized or spray dried solid active ingredient (oxitropium or tiotropium salts which are soluble in water), and coating consisting of fatty acid, alcohol derivative, and poloxamer |
09/07/2005 | EP1571155A1 Peptides and medicinal compositions containing the same |
09/07/2005 | EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists |
09/07/2005 | EP1570861A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
09/07/2005 | EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
09/07/2005 | EP1570844A2 Composition comprising pseudoephedrine and domperidone for preventing snoring |
09/07/2005 | EP1569907A1 Nicotinamide-based kinase inhibitors |
09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
09/07/2005 | EP1569631A1 A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
09/07/2005 | EP1458717B1 Aroyl pyridinones |
09/07/2005 | EP1443952A4 A method of reducing mortality and morbidity associated with critical illnesses |
09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
09/07/2005 | EP1335740B1 Preparations having effect against allergic symptoms and their manufacturing method |
09/07/2005 | EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
09/07/2005 | EP1192132B1 Serine protease inhibitors |
09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
09/07/2005 | CN1665809A Azaindoles |
09/07/2005 | CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism |
09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
09/07/2005 | CN1665789A Diaminopyrimidinecarboxa mide derivative |
09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
09/07/2005 | CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives |
09/07/2005 | CN1665539A Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors |
09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
09/07/2005 | CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
09/07/2005 | CN1665506A 2, 5-substituted pyrimidine derivatives as CCR-3 receptor antagonists IX |
09/07/2005 | CN1665505A 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
09/07/2005 | CN1663614A 复方氨溴索和头孢菌素类制剂及其应用 Compound ambroxol and cephalosporins preparation and its application |
09/07/2005 | CN1663610A Lysozyme preparation |
09/07/2005 | CN1663604A Spray for treating chronic pharyngitis |
09/07/2005 | CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage |
09/07/2005 | CN1663590A Buccal tablet of chrysanthemum flower |
09/07/2005 | CN1663584A Throat-moistening lozenge with pearl |
09/07/2005 | CN1663582A Medicine for treating chronic bronchitis and its preparation method |
09/07/2005 | CN1663574A Cough-stopping throat-clearing medicament made from chrysanthemum flower |
09/07/2005 | CN1217669C Naringin used in preparing medicine for curing acute and chronic bronchitis |
09/07/2005 | CN1217660C IL-8 receptor antagonists |
09/07/2005 | CN1217655C Fibrauretine slow releasing preparation |
09/07/2005 | CN1217654C Metered dose inhaler for albuterol |
09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
09/06/2005 | US6939889 Quarternary ammonium compounds |
09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
09/06/2005 | CA2193329C Water soluble rapamycin esters |
09/01/2005 | WO2005080419A1 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof |
09/01/2005 | WO2005080385A1 Indanol derivative |
09/01/2005 | WO2004056310A3 Methods of diagnosis and treatment of interstitial lung disease |
09/01/2005 | WO2002083873A3 Enzymes |